Identity on this record
Chemical name: Synthetic thymosin beta-4 fragment (research supply designation TB-500).
Common synonyms: Thymosin beta-4 fragment, TB4 fragment, LKKTETQ peptide.
Parent protein: Thymosin beta-4 (43 residues).
Appearance: White lyophilised powder.
Material class: Actin-binding peptide fragment.
Those identifiers describe TB-500 as a substance. They do not describe a particular vial. The vial is identified by the name, the nominal fill, and the lot number on its label, checked against the published certificate.
What the catalogue actually sells
TB-500 5mg is the 5 mg lyophilized unit, listed at AED 349 before VAT. The product record stores that sealed unit at 2–8 °C · protect from light.
Prices are merchandise prices in AED, exclusive of VAT. VAT is added at checkout. A price on this summary is the figure on the product record for TB-500, not a delivered-cost quote.
Lots and certificates
Lot VL-TB500-20260917 is the catalogue certificate for TB-500 5mg. Read it on TB-500 5mg certificate and match the vial in batch verification. A certificate for a different strength, or for a blend that merely contains the same name, does not release this unit.
How the compound record describes the literature
Thymosin Beta-4 was characterized in the 1980s; the TB-500 fragment nomenclature appears in research supply contexts referencing the active region studied in migration models.
Topics named on the TB-500 record, as literature context rather than as outcomes VaultLabs claims: Cell migration assays; Actin cytoskeleton studies; Cardiac and dermal fibroblast models; Wound closure kinetics (in vitro).
That is context for identifying TB-500. It is not a claim that a vial produces a result in a person, an animal, or a study VaultLabs has not published. VaultLabs does not provide dosage, administration, study-design, or medical guidance.
Points the monograph already states
Points already written on the TB-500 monograph, so a reader can check them against that page:
TB-500 is a fragment-based synthetic peptide, not thymosin beta-4 itself; the two names are frequently and incorrectly used interchangeably in commercial listings.
The sequence most often referenced in supply contexts is the LKKTETQ actin-binding motif of thymosin beta-4.
Research themes centre on actin cytoskeleton dynamics, cell migration and wound-closure kinetics in culture.
Thymosin beta-4 and its fragments are prohibited in sport under the World Anti-Doping Agency list.
Because product naming in this category is inconsistent across suppliers, the certificate of analysis and the stated sequence matter more than the trade name.
Dispatch and the research-use boundary
VaultLabs dispatches TB-500 from Dubai. Orders leave fulfillment within 24 hours, 7 days a week. Standard delivery is AED 35 to every emirate, and delivery is free when the post-discount merchandise subtotal is AED 500 or more. Checkout shows the fee for the address entered. All VaultLabs products are supplied strictly for laboratory and research use only. They are not intended for human consumption, medical use, personal use, or diagnostic use. VaultLabs does not provide dosage, administration, study-design, or medical guidance.
The full narrative record is the TB-500 compound monograph. Handling of the sealed unit is the TB-500 storage guide. Questions are collected on the TB-500 FAQ. How it differs from neighbouring records is the TB-500 comparison.